NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Clinical Study of the Effect of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-041)

CompletedPhase 1

Sponsor: Merck Sharp & Dohme LLC

Conditions: Healthy

Interventions: Enlicitide

Countries: United States

The goal of this study is to learn what happens to enlicitide (MK-0616) in a healthy person's body over time (pharmacokinetic or PK study). Researchers also want to learn about the safety of enlicitide and if people tolerate it.

Eligibility overview

Sex: ALL

Age: 19 Years to 55 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

The key inclusion criteria include but are not limited to the following:

* Is in good health
* Has a body-mass index (BMI) between 18 and 32 kg/m\^2

Exclusion Criteria:

The key exclusion criteria include but are not limited to the following:

* Has a history of clinically significant gastrointestinal disease that may impact drug absorption
* Has a history of cancer (malignancy)

Locations (1)

Lincoln, Nebraska, United States